Update re AbC-19 Rapid Test

RNS Number : 9048J

Omega Diagnostics Group PLC

29 December 2020

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Update re AbC-19^TM Rapid Test

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes today's update from Abingdon Health plc (AIM: ABDX) regarding the AbC-19^TM Rapid Test and welcomes confirmation that they continue to work constructively with the Medicines and Healthcare products Regulatory Agency (MHRA) to try to enable approval for home use and self-test of the AbC-19^TM Rapid Test in the UK.

Abingdon have also confirmed that whilst the DHSC continues to have first refusal for supplies of the AbC-19^TM Rapid Test through a Supply of Goods Contract that extends to 14 February 2021, the UK-RTC is liaising with customers and regulatory authorities across a total of 27 international territories, to allow future use of the product outside of the UK.

Colin King, CEO of Omega Diagnostics, said: "We welcome the update from Abingdon Health this morning and we look forward to being able to update investors on this approval process for self-test use in due course. We remain confident that the AbC-19^TM Rapid Test has a potential global application and we are delighted that the UK-RTC maintains constructive dialogue with interested customers and regulatory authorities across the world."

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Edward Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]

 

END

 

 

NRAGZMZZMRZGGZZ